Skip to content
WeighLab

Mevo Health vs Intimate Rose

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Mevo Health

Provider comparison

Patients who want a named physician-led network and can confirm their medication price and plan term before paying.

Semaglutide / month
From $199/moCompounded injection; dose and plan term require confirmation
Tirzepatide / month
From $259/moCompounded injection; dose and plan term require confirmation
Index 59/100 · Grade CChecked October 2026

Intimate Rose

Provider comparison

Existing Intimate Rose customers who want to evaluate its OpenLoop-supported weight-management program and will compare the exact prescribed plan.

Semaglutide / month
Not separately disclosed (GLP-1 program from $169/mo)
Tirzepatide / month
Not disclosed
Index 58/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Mevo Health has the higher Cost-Efficiency Index: 59/100 versus 58/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Mevo Health

Intimate Rose

Semaglutide / month
Mevo Health: From $199/moCompounded injection; dose and plan term require confirmation
Intimate Rose: Not separately disclosed (GLP-1 program from $169/mo)
Tirzepatide / month
Mevo Health: From $259/moCompounded injection; dose and plan term require confirmation
Intimate Rose: Not disclosed
Semaglutide / year (modeled)
Mevo Health: $2,388
Intimate Rose: —
Tirzepatide / year (modeled)
Mevo Health: $3,108
Intimate Rose: —
State availability
Mevo Health: Coverage not published
Intimate Rose: Coverage not published
Oral / sublingual option listed
Mevo Health: Not listed
Intimate Rose: Yes
Brand-name access listed
Mevo Health: Not confirmed
Intimate Rose: Not confirmed
Provider facts checked
Mevo Health: October 2026
Intimate Rose: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Mevo Health

Patients who want a named physician-led network and can confirm their medication price and plan term before paying.

Reasons to consider it

  • Named, board-certified Medical Director (Dr. David Wasef) heading a stated provider network
  • LegitScript verification badge displayed
  • Publishes the FDA compounded-medication disclaimer verbatim

What to weigh up

  • The $199/$259 floors are not tied to a specific dose or plan length on the public page
  • Plans include monthly, quarterly and six-month options; confirm the full charge
  • The dispensing pharmacy is not identified before ordering

Intimate Rose

Existing Intimate Rose customers who want to evaluate its OpenLoop-supported weight-management program and will compare the exact prescribed plan.

Reasons to consider it

  • Names OpenLoop Health as the clinical and pharmacy network
  • Lists compounded semaglutide and tirzepatide, including oral options
  • Says provider review, medication, delivery and check-ins are included

What to weigh up

  • The $169 starting price is program-wide, with no separate drug or dose pricing
  • The individual prescriber and dispensing pharmacy are not named before assessment
  • No treatment-specific state list, prescription refund rule or renewal cancellation deadline is published

Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Mevo HealthIntimate Rose
Normalized Cost/Month
Mevo Health:
55/100
Intimate Rose:
45/100
Price Transparency
Mevo Health:
78/100
Intimate Rose:
86/100
Nationwide Access
Mevo Health:
24/100
Intimate Rose:
24/100
Formulation Options
Mevo Health:
66/100
Intimate Rose:
77/100
Clinical Oversight
Mevo Health:
73/100
Intimate Rose:
64/100
Contract Flexibility
Mevo Health:
63/100
Intimate Rose:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.